The effect of prebiotic supplementation on serum levels of tryptophan and kynurenine in obese women with major depressive disorder: a double-blinded placebo-controlled randomized clinical trial

被引:0
作者
Khademi, Fatemeh [1 ]
Tutunchi, Helda [2 ]
Vaghef-Mehrabani, Elnaz [3 ]
Ebrahimi-Mameghani, Mehrangiz [4 ]
机构
[1] Tabriz Univ Med Sci, Student Res Comm, Tabriz, Iran
[2] Tabriz Univ Med Sci, Endocrine Res Ctr, Tabriz, Iran
[3] Cumming Sch Med, Dept Pediat, Calgary, AB, Canada
[4] Tabriz Univ Med Sci, Fac Nutr & Food Sci, Nutr Res Ctr, Dept Biochem & Diet Therapy, Tabriz, Iran
关键词
Major depressive disorder (MDD); Obesity; Prebiotics; Tryptophan (Trp); Kynurenine (Kyn); Inulin; WEIGHT-LOSS DIET; CALORIC RESTRICTION; OVERWEIGHT; ASSOCIATION; ADULTS; LIFE;
D O I
10.1186/s13104-024-06963-w
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
ObjectiveThe objective of the present study was to examine the effect of calorie restricted diet (CRD) plus inulin supplementation on serum levels of tryptophan (Trp), kynurenine (Kyn) and Trp/Kyn ratio in obese women with major depressive disorder (MDD).ResultsIn this double-blind placebo-controlled randomized clinical trial, 51 obese women (BMI = 30-40 kg/m2) with mild MDD were assessed for depression level using Hamilton depression rating scale (HDRS). The patients were randomly allocated into either "Prebiotic group" (received 10 g/day inulin) or "Placebo group" (received 10 g/day maltodextrin). All participants also received individualized CRD. Fasting serum levels of Trp, Kyn, and Trp/Kyn ratio were assessed at baseline and after 8 weeks. Results showed slightly greater increases in serum levels of Trp and Trp/Kyn ratio as well as reductions in serum level of Kyn and HDRS score in prebiotic group than placebo group. However, between group differences in these parameters as well as HDRS score were not statistically significant after adjusting for baseline variables at the end of the trial. Results indicates that CRD accompanied by inulin supplementation (10 g/day) did not influence serum levels of Trp, Kyn and Trp/Kyn ratio as well as HDRS score after 8 weeks.Trial registration: The trial was registered in the Iranian registry of clinical trials at 2018-08-02 (https://www.irct.ir/; registration number: IRCT20100209003320N15).ResultsIn this double-blind placebo-controlled randomized clinical trial, 51 obese women (BMI = 30-40 kg/m2) with mild MDD were assessed for depression level using Hamilton depression rating scale (HDRS). The patients were randomly allocated into either "Prebiotic group" (received 10 g/day inulin) or "Placebo group" (received 10 g/day maltodextrin). All participants also received individualized CRD. Fasting serum levels of Trp, Kyn, and Trp/Kyn ratio were assessed at baseline and after 8 weeks. Results showed slightly greater increases in serum levels of Trp and Trp/Kyn ratio as well as reductions in serum level of Kyn and HDRS score in prebiotic group than placebo group. However, between group differences in these parameters as well as HDRS score were not statistically significant after adjusting for baseline variables at the end of the trial. Results indicates that CRD accompanied by inulin supplementation (10 g/day) did not influence serum levels of Trp, Kyn and Trp/Kyn ratio as well as HDRS score after 8 weeks.Trial registration: The trial was registered in the Iranian registry of clinical trials at 2018-08-02 (https://www.irct.ir/; registration number: IRCT20100209003320N15).
引用
收藏
页数:7
相关论文
共 50 条
  • [41] Pentoxifylline as a Novel Add-on Therapy for Major Depressive Disorder in Adult Patients: A Randomized, Double-Blind, Placebo-Controlled Trial
    Mohammad, Talar A. Merza
    Mohammad, Tavgah A. Merza
    Salman, Dyar M.
    Jaafar, Halmat M.
    PHARMACOPSYCHIATRY, 2024, 57 (04) : 205 - 214
  • [42] The Effect of Saffron Kozanis (Crocus sativus L.) Supplementation on Weight Management, Glycemic Markers and Lipid Profile in Adolescents with Obesity: A Double-Blinded Randomized Placebo-Controlled Trial
    Kotanidou, Eleni P.
    Tsinopoulou, Vasiliki Rengina
    Giza, Styliani
    Ntouma, Stergianna
    Angeli, Chrysanthi
    Chatziandreou, Michail
    Tsopelas, Konstantinos
    Tseti, Ioulia
    Galli-Tsinopoulou, Assimina
    CHILDREN-BASEL, 2023, 10 (11):
  • [43] High- vs low-dose oxytocin in lean and obese women: a double-blinded randomized controlled trial
    Wei, Ruth M.
    Bounthavong, Mark
    Hill, Meghan G.
    AMERICAN JOURNAL OF OBSTETRICS & GYNECOLOGY MFM, 2022, 4 (04)
  • [44] Acid Folic Supplementation in Major Depressive Disorder Treatment: A Double-Blind Randomized Clinical Trial
    Sepehrmanesh, Zahra
    Omidi, Abdollah
    Gholampoor, Narges
    IRANIAN RED CRESCENT MEDICAL JOURNAL, 2017, 19 (02)
  • [45] The effect ofNigella sativasupplementation on cardiovascular risk factors in obese and overweight women: a crossover, double-blind, placebo-controlled randomized clinical trial
    Razmpoosh, Elham
    Safi, Sara
    Nadjarzadeh, Azadeh
    Fallahzadeh, Hossien
    Abdollahi, Nooshin
    Mazaheri, Mahta
    Nazari, Majid
    Salehi-Abargouei, Amin
    EUROPEAN JOURNAL OF NUTRITION, 2021, 60 (04) : 1863 - 1874
  • [46] The Effects of Chromium Supplementation on Gene Expression of Insulin, Lipid, and Inflammatory Markers in Infertile Women With Polycystic Ovary Syndrome Candidate for in vitro Fertilization: A Randomized, Double-Blinded, Placebo-Controlled Trial
    Siavashani, Mehrnush Amiri
    Modarres, Shahrzad Zadeh
    Mirhosseini, Naghmeh
    Aghadavod, Esmat
    Salehpour, Saghar
    Asemi, Zatollah
    FRONTIERS IN ENDOCRINOLOGY, 2018, 9
  • [47] Effect of oligofructose supplementation on body weight in overweight and obese children: a randomised, double-blind, placebo-controlled trial
    Liber, Anna
    Szajewska, Hania
    BRITISH JOURNAL OF NUTRITION, 2014, 112 (12) : 2068 - 2074
  • [48] Consumption of Solnul™ Resistant Potato Starch Produces a Prebiotic Effect in a Randomized, Placebo-Controlled Clinical Trial
    Bush, Jason R.
    Baisley, Joshua
    Harding, Scott V.
    Alfa, Michelle J.
    NUTRIENTS, 2023, 15 (07)
  • [49] Beneficial effects of colchicine for moderate to severe COVID-19: a randomised, double-blinded, placebo-controlled clinical trial
    Lopes, Maria Isabel
    Bonjorno, Leticia P.
    Giannini, Marcela C.
    Amaral, Natalia B.
    Menezes, Pamella Indira
    Dib, Saulo Musse
    Gigante, Samara Libich
    Benatti, Maira N.
    Rezek, Uebe C.
    Emrich-Filho, Laerte L.
    Sousa, Betania A. A.
    Almeida, Sergio C. L.
    Luppino Assad, Rodrigo
    Veras, Flavio P.
    Schneider, Ayda
    Rodrigues, Tamara S.
    Leiria, Luiz O. S.
    Cunha, Larissa D.
    Alves-Filho, Jose C.
    Cunha, Thiago M.
    Arruda, Eurico
    Miranda, Carlos H.
    Pazin-Filho, Antonio
    Auxiliadora-Martins, Maria
    Borges, Marcos C.
    Fonseca, Benedito A. L.
    Bollela, Valdes R.
    Del-Ben, Cristina M.
    Cunha, Fernando Q.
    Zamboni, Dario S.
    Santana, Rodrigo C.
    Vilar, Fernando C.
    Louzada-Junior, Paulo
    Oliveira, Rene D. R.
    RMD OPEN, 2021, 7 (01):
  • [50] A randomized, double-blinded, placebo-controlled, single-center, comparative study evaluating Phaseolean® safety and efficacy in overweight/obese participants
    Singh, Shashi Chandrama
    Singh, Harshpal
    Choudhary, Muskan
    HELIYON, 2024, 10 (15)